236 related articles for article (PubMed ID: 15358834)
1. Gene expression profiling identifies a unique androgen-mediated inflammatory/immune signature and a PTEN (phosphatase and tensin homolog deleted on chromosome 10)-mediated apoptotic response specific to the rat ventral prostate.
Desai KV; Michalowska AM; Kondaiah P; Ward JM; Shih JH; Green JE
Mol Endocrinol; 2004 Dec; 18(12):2895-907. PubMed ID: 15358834
[TBL] [Abstract][Full Text] [Related]
2. Prostate carcinomas developing in transgenic rats with SV40 T antigen expression under probasin promoter control are strictly androgen dependent.
Asamoto M; Hokaiwado N; Cho YM; Takahashi S; Ikeda Y; Imaida K; Shirai T
Cancer Res; 2001 Jun; 61(12):4693-700. PubMed ID: 11406539
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of CCAAT/enhancer-binding protein-delta (c/EBPdelta) in rat androgen-dependent tissues and human prostate cancer.
Yang G; Gregory CW; Shang Q; O'Brien DA; Zhang YL
J Androl; 2001; 22(3):471-80. PubMed ID: 11330648
[TBL] [Abstract][Full Text] [Related]
4. Expression and regulation of metallothionein mRNA levels in the prostates of noble rats: lack of expression in the ventral prostate and regulation by sex hormones in the dorsolateral prostate.
Ghatak S; Oliveria P; Kaplan P; Ho SM
Prostate; 1996 Aug; 29(2):91-100. PubMed ID: 8700805
[TBL] [Abstract][Full Text] [Related]
5. Dysregulation of sterol response element-binding proteins and downstream effectors in prostate cancer during progression to androgen independence.
Ettinger SL; Sobel R; Whitmore TG; Akbari M; Bradley DR; Gleave ME; Nelson CC
Cancer Res; 2004 Mar; 64(6):2212-21. PubMed ID: 15026365
[TBL] [Abstract][Full Text] [Related]
6. Regulation of androgen receptor signaling by PTEN (phosphatase and tensin homolog deleted on chromosome 10) tumor suppressor through distinct mechanisms in prostate cancer cells.
Lin HK; Hu YC; Lee DK; Chang C
Mol Endocrinol; 2004 Oct; 18(10):2409-23. PubMed ID: 15205473
[TBL] [Abstract][Full Text] [Related]
7. Androgens regulate the immune/inflammatory response and cell survival pathways in rat ventral prostate epithelial cells.
Asirvatham AJ; Schmidt M; Gao B; Chaudhary J
Endocrinology; 2006 Jan; 147(1):257-71. PubMed ID: 16195407
[TBL] [Abstract][Full Text] [Related]
8. CCAAT/enhancer-binding protein delta: a molecular target of 1,25-dihydroxyvitamin D3 in androgen-responsive prostate cancer LNCaP cells.
Ikezoe T; Gery S; Yin D; O'Kelly J; Binderup L; Lemp N; Taguchi H; Koeffler HP
Cancer Res; 2005 Jun; 65(11):4762-8. PubMed ID: 15930295
[TBL] [Abstract][Full Text] [Related]
9. Expression profiling of the mouse prostate after castration and hormone replacement: implication of H-cadherin in prostate tumorigenesis.
Wang XD; Wang BE; Soriano R; Zha J; Zhang Z; Modrusan Z; Cunha GR; Gao WQ
Differentiation; 2007 Mar; 75(3):219-34. PubMed ID: 17288544
[TBL] [Abstract][Full Text] [Related]
10. TNF-alpha-related apoptosis-inducing ligand decoy receptor DcR2 is targeted by androgen action in the rat ventral prostate.
Vindrieux D; Réveiller M; Florin A; Blanchard C; Ruffion A; Devonec M; Benahmed M; Grataroli R
J Cell Physiol; 2006 Mar; 206(3):709-17. PubMed ID: 16245307
[TBL] [Abstract][Full Text] [Related]
11. FOXO proteins regulate tumor necrosis factor-related apoptosis inducing ligand expression. Implications for PTEN mutation in prostate cancer.
Modur V; Nagarajan R; Evers BM; Milbrandt J
J Biol Chem; 2002 Dec; 277(49):47928-37. PubMed ID: 12351634
[TBL] [Abstract][Full Text] [Related]
12. Conditional expression of PTEN alters the androgen responsiveness of prostate cancer cells.
Wu Z; Conaway M; Gioeli D; Weber MJ; Theodorescu D
Prostate; 2006 Jul; 66(10):1114-23. PubMed ID: 16637073
[TBL] [Abstract][Full Text] [Related]
13. Intraprostatic androgens and androgen-regulated gene expression persist after testosterone suppression: therapeutic implications for castration-resistant prostate cancer.
Mostaghel EA; Page ST; Lin DW; Fazli L; Coleman IM; True LD; Knudsen B; Hess DL; Nelson CC; Matsumoto AM; Bremner WJ; Gleave ME; Nelson PS
Cancer Res; 2007 May; 67(10):5033-41. PubMed ID: 17510436
[TBL] [Abstract][Full Text] [Related]
14. Castration-induced increases in insulin-like growth factor-binding protein 2 promotes proliferation of androgen-independent human prostate LNCaP tumors.
Kiyama S; Morrison K; Zellweger T; Akbari M; Cox M; Yu D; Miyake H; Gleave ME
Cancer Res; 2003 Jul; 63(13):3575-84. PubMed ID: 12839944
[TBL] [Abstract][Full Text] [Related]
15. Genome-wide expression profiling reveals transcriptomic variation and perturbed gene networks in androgen-dependent and androgen-independent prostate cancer cells.
Singh AP; Bafna S; Chaudhary K; Venkatraman G; Smith L; Eudy JD; Johansson SL; Lin MF; Batra SK
Cancer Lett; 2008 Jan; 259(1):28-38. PubMed ID: 17977648
[TBL] [Abstract][Full Text] [Related]
16. Quantitative determination of lobe specificity of mRNA expression of androgen-dependent genes in the rat prostate gland.
Suzuki T; Fujimoto N; Kitamura S; Ohta S
Endocr J; 2007 Feb; 54(1):123-32. PubMed ID: 17146147
[TBL] [Abstract][Full Text] [Related]
17. Androgen ablation results in differential regulation of transforming growth factor-beta isoforms in rat male accessory sex organs and epididymis.
Desai KV; Kondaiah P
J Mol Endocrinol; 2000 Apr; 24(2):253-60. PubMed ID: 10750026
[TBL] [Abstract][Full Text] [Related]
18. Posterior Hox gene expression and differential androgen regulation in the developing and adult rat prostate lobes.
Huang L; Pu Y; Hepps D; Danielpour D; Prins GS
Endocrinology; 2007 Mar; 148(3):1235-45. PubMed ID: 17138648
[TBL] [Abstract][Full Text] [Related]
19. A rare castration-resistant progenitor cell population is highly enriched in Pten-null prostate tumours.
Sackmann Sala L; Boutillon F; Menara G; De Goyon-Pélard A; Leprévost M; Codzamanian J; Lister N; Pencik J; Clark A; Cagnard N; Bole-Feysot C; Moriggl R; Risbridger GP; Taylor RA; Kenner L; Guidotti JE; Goffin V
J Pathol; 2017 Sep; 243(1):51-64. PubMed ID: 28603917
[TBL] [Abstract][Full Text] [Related]
20. Regional expression of transforming growth factor-alpha in rat ventral prostate during postnatal development, after androgen ablation, and after androgen replacement.
Banerjee S; Banerjee PP; Zirkin BR; Brown TR
Endocrinology; 1998 Jun; 139(6):3005-13. PubMed ID: 9607812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]